Low risk TAVR: Long- term considerations and appropriate patient selection.
Price J, Bob-Manuel T, Aymond J, Amoran O, Almusawi H, Kelly J, Okor I, Okoro K, Ramee S, Tafur J.
Price J, et al.
Prog Cardiovasc Dis. 2020 May-Jun;63(3):377-382. doi: 10.1016/j.pcad.2020.04.002. Epub 2020 Apr 8.
Prog Cardiovasc Dis. 2020.
PMID: 32277996
Review.